Christopher Causey - Net Worth and Insider Trading

Christopher Causey Net Worth

The estimated net worth of Christopher Causey is at least $981,257 dollars as of 2024-04-23. Christopher Causey is the Director of United Therapeutics Corp and owns about 4,185 shares of United Therapeutics Corp (UTHR) stock worth over $981,257. Details can be seen in Christopher Causey's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Causey has not made any transactions after 2023-12-15 and currently still holds the listed stock(s).

Transaction Summary of Christopher Causey

To

Christopher Causey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Causey owns 1 companies in total, including United Therapeutics Corp (UTHR) .

Click here to see the complete history of Christopher Causey’s form 4 insider trades.

Insider Ownership Summary of Christopher Causey

Ticker Comapny Transaction Date Type of Owner
UTHR United Therapeutics Corp 2023-12-15 director

Christopher Causey Latest Holdings Summary

Christopher Causey currently owns a total of 1 stock. Christopher Causey owns 4,185 shares of United Therapeutics Corp (UTHR) as of December 15, 2023, with a value of $981,257.

Latest Holdings of Christopher Causey

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
UTHR United Therapeutics Corp 2023-12-15 4,185 234.47 981,257

Holding Weightings of Christopher Causey


Christopher Causey Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Causey has made a total of 7 transactions in United Therapeutics Corp (UTHR) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in United Therapeutics Corp is the sale of 400 shares on December 15, 2023, which brought Christopher Causey around $102,000.

Insider Trading History of Christopher Causey

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Causey Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Causey Ownership Network

Ownership Network List of Christopher Causey

No Data

Ownership Network Relation of Christopher Causey


Christopher Causey Owned Company Details

What does United Therapeutics Corp do?

Who are the key executives at United Therapeutics Corp?

Christopher Causey is the director of United Therapeutics Corp. Other key executives at United Therapeutics Corp include director & Chief Executive Officer Martine A Rothblatt , EVP & General Counsel Paul A Mahon , and President and COO Michael Benkowitz .

United Therapeutics Corp (UTHR) Insider Trades Summary

Over the past 18 months, Christopher Causey made 3 insider transaction in United Therapeutics Corp (UTHR) with a net sale of 10,900. Other recent insider transactions involving United Therapeutics Corp (UTHR) include a net sale of 1,310,885 shares made by Martine A Rothblatt , a net sale of 206,500 shares made by Paul A Mahon , and a net sale of 1,977 shares made by Nilda Mesa .

In summary, during the past 3 months, insiders sold 427,890 shares of United Therapeutics Corp (UTHR) in total and bought 0 shares, with a net sale of 427,890 shares. During the past 18 months, 1,547,602 shares of United Therapeutics Corp (UTHR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,547,602 shares.

United Therapeutics Corp (UTHR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

United Therapeutics Corp Insider Transactions

No Available Data

Christopher Causey Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Causey. Currently GuruFocus does not have mailing address information for Christopher Causey.

Discussions on Christopher Causey

No discussions yet.